{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:20:08Z","timestamp":1791120008376,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.amjcard.2008.06.007","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T17:31:31Z","timestamp":1220808691000},"page":"21G-28G","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S","title":["Pharmacologic Therapies Across the Continuum of Left Ventricular Dysfunction"],"prefix":"10.1016","volume":"102","author":[{"given":"William T.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry H.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde W.","family":"Yancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2008.06.007_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","article-title":"ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"46","author":"Hunt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2008.06.007_bib2","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.105.600437","article-title":"Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction","volume":"113","author":"Goldberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.06.007_bib3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/0002-8703(93)90656-T","article-title":"Short- and long-term neurohormonal activation following acute myocardial infarction","volume":"126","author":"Sigurdsson","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2008.06.007_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1185\/030079906X80233","article-title":"The effect of neurohormonal antagonists in reducing heart failure hospitalizations","volume":"22","author":"Williams","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2008.06.007_bib5","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0002-9440(10)65037-7","article-title":"Up-regulation of AT1 and AT2 receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death","volume":"156","author":"Leri","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjcard.2008.06.007_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1006\/jmcc.2002.2088","article-title":"Molecular mechanisms of myocardial remodeling: the role of aldosterone","volume":"34","author":"Delcayre","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.amjcard.2008.06.007_bib7","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.amjcard.2008.06.007_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.85.2.790","article-title":"Adrenergic effects on the biology of the adult mammalian cardiocyte","volume":"85","author":"Mann","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.06.007_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib11","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib15","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/hrt.69.3.215","article-title":"Early treatment with captopril after acute myocardial infarction","volume":"69","author":"Ray","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.amjcard.2008.06.007_bib18","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib19","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM198104023041401","article-title":"Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction","volume":"304","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction","volume":"247","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.06.007_bib23","first-page":"I26","article-title":"The G\u00f6teborg Metoprolol Trial: effects on mortality and morbidity in acute myocardial infarction","volume":"67","author":"Hjalmarson","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.06.007_bib24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib25","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000089970","article-title":"Managing the post-myocardial infarction patient with asymptomatic left ventricular dysfunction","volume":"105","author":"Philippides","year":"2006","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2008.06.007_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","article-title":"Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy","volume":"109","author":"Doughty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.06.007_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib34","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2008.06.007_bib35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","article-title":"The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT","volume":"25","author":"Latini","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2008.06.007_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ehj.2003.12.013","article-title":"Neurohormones in heart failure: predicting outcomes, optimizing care","volume":"25","author":"Givertz","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2008.06.007_bib37","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.CIR.99.6.786","article-title":"Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction","volume":"99","author":"Richards","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.06.007_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-005-6127-6","article-title":"Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry","volume":"9","author":"Fonarow","year":"2004","journal-title":"Heart Fail Rev"},{"issue":"suppl 4","key":"10.1016\/j.amjcard.2008.06.007_bib39","first-page":"S18","article-title":"Pharmacologic therapies for acutely decompensated heart failure","volume":"3","author":"Fonarow","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cardfail.2005.12.001","article-title":"Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline","volume":"12","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2008.06.007_bib41","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/hc1102.105264","article-title":"BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.06.007_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-8703(02)94708-3","article-title":"Vasopressin: a new target for the treatment of heart failure","volume":"146","author":"Lee","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2008.06.007_bib43","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.06.007_bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure","volume":"343","author":"Colucci","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.06.007_bib45","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2008.06.007_bib46","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.06.007_bib47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ejheart.2006.10.001","article-title":"Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF","volume":"8","author":"Cleland","year":"2006","journal-title":"Eur J Heart Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914908009971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914908009971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T04:28:02Z","timestamp":1545798482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914908009971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0002914908009971"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2008.06.007","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}